Financial statements Instytut Badawczo - Rozwojowy Biogened

Balance sheet of Instytut Badawczo - Rozwojowy Biogened

Company age:
Age:
18 y. 5 m.
Share capital:
Share capital:
50 000 PLN

Balance sheet data of INSTYTUT BADAWCZO - ROZWOJOWY BIOGENED

Year
2018
2019
2020
2021
2022
Total assets 5 288 366,06 5 303 743,00 5 619 814,57 6 097 236,60 7 646 636,43
A. Fixed assets 58 758,37 55 826,85 49 395,33 43 500,00 2 250 426,83
B. Current assets 5 229 607,69 5 247 916,15 5 570 419,24 6 053 736,60 5 396 209,60
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 5 288 366,06 5 303 743,00 5 619 814,57 6 097 236,60 7 646 636,43
A. Equity 44 737,19 179 521,04 1 245 078,82 1 639 992,81 1 702 928,01
B. Liabilities and provisions for liabilities 5 243 628,87 5 124 221,96 4 374 735,75 4 457 243,79 5 943 708,42
I. Long-term liabilities - - 0,00 0,00 0,00
II. Short-term liabilities - - 4 374 735,75 4 457 243,79 4 875 763,30
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.